{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T22:06:07Z","timestamp":1795039567281,"version":"4.10.2"},"reference-count":57,"publisher":"American Society of Hematology","issue":"25","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,12,21]]},"abstract":"<jats:title>Key Points<\/jats:title>\n                  <jats:p>Early introduction of cyclosporine did not improve HLH outcome in patients treated with the HLH-94 etoposide-dexamethasone backbone (P = .06). HLH-2004 may be improved by risk-group stratification, less therapy reduction weeks 7 to 8 for verified FHL patients, and earlier HSCT.<\/jats:p>","DOI":"10.1182\/blood-2017-06-788349","type":"journal-article","created":{"date-parts":[[2017,9,21]],"date-time":"2017-09-21T21:10:49Z","timestamp":1506028249000},"page":"2728-2738","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":599,"title":["Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study"],"prefix":"10.1182","volume":"130","author":[{"given":"Elisabet","family":"Bergsten","sequence":"first","affiliation":[{"name":"Childhood Cancer Research Unit, Department of Women\u2019s and Children\u2019s Health, Karolinska Institute, Stockholm, Sweden;"},{"name":"Theme of Children\u2019s and Women\u2019s Health, Karolinska University Hospital, Stockholm, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AnnaCarin","family":"Horne","sequence":"additional","affiliation":[{"name":"Childhood Cancer Research Unit, Department of Women\u2019s and Children\u2019s Health, Karolinska Institute, Stockholm, Sweden;"},{"name":"Theme of Children\u2019s and Women\u2019s Health, Karolinska University Hospital, Stockholm, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Aric\u00f3","sequence":"additional","affiliation":[{"name":"Direzione Generale, Azienda Sanitaria Provinciale, Ragusa, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itziar","family":"Astigarraga","sequence":"additional","affiliation":[{"name":"Servicio de Pediatria, BioCruces Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Universidad del Pais Vasco\u2013Euskal Herriko Unibertsitatea (UPV\/EHU), Barakaldo, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Maarten","family":"Egeler","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, The Hospital for Sick Children, Toronto, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra H.","family":"Filipovich","sequence":"additional","affiliation":[{"name":"Division of Bone Marrow Transplant and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichi","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Graduate School of Medicine, Ehime University, Ehime, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gritta","family":"Janka","sequence":"additional","affiliation":[{"name":"Pediatric Hematology and Oncology, University Medical Center Hamburg, Hamburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Ladisch","sequence":"additional","affiliation":[{"name":"Center for Cancer and Immunology Research, Children's Research Institute, Children's National Medical Center, Washington, DC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Lehmberg","sequence":"additional","affiliation":[{"name":"Pediatric Hematology and Oncology, University Medical Center Hamburg, Hamburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth L.","family":"McClain","sequence":"additional","affiliation":[{"name":"Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milen","family":"Minkov","sequence":"additional","affiliation":[{"name":"University Clinic of Pediatrics, St. Anna Children's Hospital, Medical University of Vienna, Vienna, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Montgomery","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Unit, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden;"},{"name":"Clinical Epidemiology and Biostatistics, School of Medical Sciences, \u00d6rebro University, \u00d6rebro, Sweden;"},{"name":"Department of Epidemiology and Public Health, University College London, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasanta","family":"Nanduri","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Watford General Hospital, Watford, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Rosso","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, Hospital de Ni\u00f1os Dr Pedro De Elizalde, Buenos Aires, Argentina;"},{"name":"Department of Pediatrics, Hospital de Clinicas Jose de San Martin, Buenos Aires, Argentina;"},{"name":"Instituto de Farmacolog\u00eda, Universidad de Buenos Aires, Buenos Aires, Argentina; and"},{"name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas (CONICET), Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Inge","family":"Henter","sequence":"additional","affiliation":[{"name":"Childhood Cancer Research Unit, Department of Women\u2019s and Children\u2019s Health, Karolinska Institute, Stockholm, Sweden;"},{"name":"Theme of Children\u2019s and Women\u2019s Health, Karolinska University Hospital, Stockholm, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"3","key":"2019111903502380700_B1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF00443367","article-title":"Familial hemophagocytic lymphohistiocytosis","volume":"140","author":"Janka","year":"1983","journal-title":"Eur J Pediatr"},{"issue":"22","key":"2019111903502380700_B2","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1182\/blood-2016-01-690636","article-title":"Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages","volume":"127","author":"Emile","year":"2016","journal-title":"Blood"},{"issue":"5446","key":"2019111903502380700_B3","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1126\/science.286.5446.1957","article-title":"Perforin gene defects in familial hemophagocytic lymphohistiocytosis","volume":"286","author":"Stepp","year":"1999","journal-title":"Science"},{"issue":"4","key":"2019111903502380700_B4","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0092-8674(03)00855-9","article-title":"Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3)","volume":"115","author":"Feldmann","year":"2003","journal-title":"Cell"},{"issue":"12","key":"2019111903502380700_B5","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1172\/JCI40732","article-title":"Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells","volume":"119","author":"C\u00f4te","year":"2009","journal-title":"J Clin Invest"},{"issue":"4","key":"2019111903502380700_B6","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ajhg.2009.09.005","article-title":"Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11","volume":"85","author":"zur Stadt","year":"2009","journal-title":"Am J Hum Genet"},{"issue":"2","key":"2019111903502380700_B7","doi-asserted-by":"crossref","first-page":"R52","DOI":"10.1186\/cc11256","article-title":"Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis\/sepsis\/multiple organ dysfunction syndrome\/macrophage activation syndrome: what is the treatment?","volume":"16","author":"Demirkol","year":"2012","journal-title":"Crit Care"},{"issue":"9927","key":"2019111903502380700_B8","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(13)61048-X","article-title":"Adult haemophagocytic syndrome","volume":"383","author":"Ramos-Casals","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"2019111903502380700_B9","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jaci.2015.06.048","article-title":"Genetic predisposition to hemophagocytic lymphohistiocytosis: Report on 500 patients from the Italian registry","volume":"137","author":"Cetica","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"2019111903502380700_B10","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1651-2227.1993.tb12699.x","article-title":"Familial hemophagocytic lymphohistiocytosis and viral infections","volume":"82","author":"Henter","year":"1993","journal-title":"Acta Paediatr"},{"issue":"2","key":"2019111903502380700_B11","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"2019111903502380700_B12","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/(SICI)1096-911X(199705)28:5<342::AID-MPO3>3.0.CO;2-H","article-title":"HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study group of the Histiocyte Society","volume":"28","author":"Henter","year":"1997","journal-title":"Med Pediatr Oncol"},{"issue":"4","key":"2019111903502380700_B13","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1046\/j.1365-2559.1998.00377.x","article-title":"Autopsy findings in 27 children with haemophagocytic lymphohistiocytosis","volume":"32","author":"Ost","year":"1998","journal-title":"Histopathology"},{"issue":"2","key":"2019111903502380700_B14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00431-006-0258-1","article-title":"Familial and acquired hemophagocytic lymphohistiocytosis","volume":"166","author":"Janka","year":"2007","journal-title":"Eur J Pediatr"},{"issue":"3","key":"2019111903502380700_B15","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2141.2007.06922.x","article-title":"Frequency and spectrum of central nervous system involvement in 193 children with haemophagocytic lymphohistiocytosis","volume":"140","author":"Horne","year":"2008","journal-title":"Br J Haematol"},{"issue":"15","key":"2019111903502380700_B16","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1212\/WNL.0b013e31824f800a","article-title":"CNS involvement at the onset of primary hemophagocytic lymphohistiocytosis","volume":"78","author":"Deiva","year":"2012","journal-title":"Neurology"},{"issue":"2","key":"2019111903502380700_B17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0022-3476(86)81002-2","article-title":"Allogeneic bone marrow transplantation for erythrophagocytic lymphohistiocytosis","volume":"108","author":"Fischer","year":"1986","journal-title":"J Pediatr"},{"issue":"12","key":"2019111903502380700_B18","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1182\/blood.V90.12.4743","article-title":"Treatment of familial hemophagocytic lymphohistiocytosis with bone marrow transplantation from HLA genetically nonidentical donors","volume":"90","author":"Jabado","year":"1997","journal-title":"Blood"},{"issue":"4","key":"2019111903502380700_B19","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1046\/j.1365-2141.1999.01625.x","article-title":"Improved outcome in haemophagocytic lymphohistiocytosis after bone marrow transplantation from related and unrelated donors: a single-centre experience of 12 patients","volume":"106","author":"D\u00fcrken","year":"1999","journal-title":"Br J Haematol"},{"issue":"1","key":"2019111903502380700_B20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/bmt.2010.122","article-title":"Excellent outcome of allogeneic hematopoietic SCT with reduced-intensity conditioning for the treatment of chronic active EBV infection","volume":"46","author":"Kawa","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2019111903502380700_B21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/ped.12314","article-title":"Current research on chronic active Epstein-Barr virus infection in Japan","volume":"56","author":"Fujiwara","year":"2014","journal-title":"Pediatr Int"},{"issue":"8","key":"2019111903502380700_B22","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1182\/blood.V82.8.2319.2319","article-title":"Treatment of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins, steroids, and cyclosporin A","volume":"82","author":"St\u00e9phan","year":"1993","journal-title":"Blood"},{"issue":"6","key":"2019111903502380700_B23","first-page":"1869","article-title":"Effective control of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis with immunochemotherapy","volume":"93","author":"Imashuku","year":"1999","journal-title":"Blood"},{"issue":"7","key":"2019111903502380700_B24","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1182\/blood-2002-01-0172","article-title":"Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation","volume":"100","author":"Henter","year":"2002","journal-title":"Blood"},{"issue":"3","key":"2019111903502380700_B25","doi-asserted-by":"crossref","first-page":"e622","DOI":"10.1542\/peds.2006-3164","article-title":"Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: a single-center retrospective report of 38 patients","volume":"120","author":"Mahlaoui","year":"2007","journal-title":"Pediatrics"},{"issue":"17","key":"2019111903502380700_B26","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1182\/blood-2011-06-356261","article-title":"Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol","volume":"118","author":"Trottestam","year":"2011","journal-title":"Blood"},{"issue":"2","key":"2019111903502380700_B27","first-page":"197","article-title":"Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry","volume":"10","author":"Aric\u00f2","year":"1996","journal-title":"Leukemia"},{"issue":"5","key":"2019111903502380700_B28","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1365-2141.2005.05501.x","article-title":"Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis","volume":"129","author":"Horne","year":"2005","journal-title":"Br J Haematol"},{"issue":"2","key":"2019111903502380700_B29","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/pbc.21790","article-title":"Treatment of the X-linked lymphoproliferative, Griscelli and Ch\u00e9diak-Higashi syndromes by HLH directed therapy","volume":"52","author":"Trottestam","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"2019111903502380700_B30","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0008-8749(83)90265-4","article-title":"Cyclosporin A inhibits the production of gamma interferon (IFN gamma), but does not inhibit production of virus-induced IFN alpha\/beta","volume":"78","author":"Kalman","year":"1983","journal-title":"Cell Immunol"},{"issue":"3-4","key":"2019111903502380700_B31","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3109\/10428190009148855","article-title":"Management of severe neutropenia with cyclosporin during initial treatment of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis","volume":"36","author":"Imashuku","year":"2000","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"2019111903502380700_B32","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1182\/blood-2005-05-1819","article-title":"Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis","volume":"107","author":"Cooper","year":"2006","journal-title":"Blood"},{"issue":"446","key":"2019111903502380700_B33","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"2019111903502380700_B34","volume-title":"Blood","author":"Zur Stadt","year":"2004"},{"issue":"8520","key":"2019111903502380700_B35","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/S0140-6736(86)92047-7","article-title":"Successful induction with chemotherapy including teniposide in familial erythrophagocytic lymphohistiocytosis","volume":"2","author":"Henter","year":"1986","journal-title":"Lancet"},{"issue":"3","key":"2019111903502380700_B36","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1651-2227.1991.tb11849.x","article-title":"Familial hemophagocytic lymphohistiocytosis. Clinical review based on the findings in seven children","volume":"80","author":"Henter","year":"1991","journal-title":"Acta Paediatr Scand"},{"issue":"5","key":"2019111903502380700_B37","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/pbc.21838","article-title":"Severe neurologic side effects in patients being treated for hemophagocytic lymphohistiocytosis","volume":"52","author":"Thompson","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"2019111903502380700_B38","doi-asserted-by":"crossref","first-page":"258","DOI":"10.5045\/br.2013.48.4.258","article-title":"Posterior reversible encephalopathy syndrome in pediatric patients undergoing treatment for hemophagocytic lymphohistiocytosis: clinical outcomes and putative risk factors","volume":"48","author":"Lee","year":"2013","journal-title":"Blood Res"},{"issue":"4","key":"2019111903502380700_B39","first-page":"455","article-title":"Posterior reversible encephalopathy syndrome due to pulse methylprednisolone therapy in a child","volume":"55","author":"\u0130ncecik","year":"2013","journal-title":"Turk J Pediatr"},{"key":"2019111903502380700_B40","volume-title":"Case Rep Neurol Med","author":"Morrow","year":"2015"},{"issue":"8","key":"2019111903502380700_B41","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1007\/s12098-011-0368-2","article-title":"Posterior reversible encephalopathy syndrome (PRES\/RPLS) during pulse steroid therapy in macrophage activation syndrome","volume":"78","author":"Kumar","year":"2011","journal-title":"Indian J Pediatr"},{"issue":"2","key":"2019111903502380700_B42","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1200\/JCO.1987.5.2.202","article-title":"Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemia","volume":"5","author":"Balis","year":"1987","journal-title":"J Clin Oncol"},{"issue":"2","key":"2019111903502380700_B43","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1046\/j.1365-2141.1999.01538.x","article-title":"Induction of apoptosis and caspase activation in cells obtained from familial haemophagocytic lymphohistiocytosis patients","volume":"106","author":"Fadeel","year":"1999","journal-title":"Br J Haematol"},{"issue":"1","key":"2019111903502380700_B44","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4049\/jimmunol.1302282","article-title":"Etoposide selectively ablates activated T cells to control the immunoregulatory disorder hemophagocytic lymphohistiocytosis","volume":"192","author":"Johnson","year":"2014","journal-title":"J Immunol"},{"issue":"24","key":"2019111903502380700_B45","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1056\/NEJM199112123252402","article-title":"Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia","volume":"325","author":"Pui","year":"1991","journal-title":"N Engl J Med"},{"issue":"9513","key":"2019111903502380700_B46","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0140-6736(06)68232-9","article-title":"Cytotoxic therapy for severe avian influenza A (H5N1) infection","volume":"367","author":"Henter","year":"2006","journal-title":"Lancet"},{"issue":"1","key":"2019111903502380700_B47","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/pbc.24188","article-title":"Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab","volume":"60","author":"Marsh","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"25","key":"2019111903502380700_B48","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1112802","article-title":"Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis","volume":"367","author":"De Benedetti","year":"2012","journal-title":"N Engl J Med"},{"issue":"26","key":"2019111903502380700_B49","doi-asserted-by":"crossref","first-page":"5154","DOI":"10.1182\/blood-2013-02-485623","article-title":"Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy","volume":"121","author":"Teachey","year":"2013","journal-title":"Blood"},{"issue":"13","key":"2019111903502380700_B50","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1182\/blood-2015-12-684399","article-title":"Janus kinase inhibition lessens inflammation and ameliorates disease in murine models of hemophagocytic lymphohistiocytosis","volume":"127","author":"Das","year":"2016","journal-title":"Blood"},{"issue":"1","key":"2019111903502380700_B51","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1182\/blood-2016-02-700013","article-title":"Therapeutic effect of JAK1\/2 blockade on the manifestations of hemophagocytic lymphohistiocytosis in mice","volume":"128","author":"Maschalidi","year":"2016","journal-title":"Blood"},{"issue":"11","key":"2019111903502380700_B52","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1182\/blood.V78.11.2918.2918","article-title":"Hypercytokinemia in familial hemophagocytic lymphohistiocytosis","volume":"78","author":"Henter","year":"1991","journal-title":"Blood"},{"issue":"3","key":"2019111903502380700_B53","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-10-3413","article-title":"An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder","volume":"104","author":"Jordan","year":"2004","journal-title":"Blood"},{"issue":"2","key":"2019111903502380700_B54","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/emmm.200900009","article-title":"Neutralization of IFNgamma defeats haemophagocytosis in LCMV-infected perforin- and Rab27a-deficient mice","volume":"1","author":"Pachlopnik Schmid","year":"2009","journal-title":"EMBO Mol Med"},{"issue":"6","key":"2019111903502380700_B55","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.jpeds.2011.11.046","article-title":"Diagnostic accuracy of a specific cytokine pattern in hemophagocytic lymphohistiocytosis in children","volume":"160","author":"Xu","year":"2012","journal-title":"J Pediatr"},{"issue":"26","key":"2019111903502380700_B56","doi-asserted-by":"crossref","first-page":"5824","DOI":"10.1182\/blood-2010-04-282392","article-title":"Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation","volume":"116","author":"Marsh","year":"2010","journal-title":"Blood"},{"issue":"11","key":"2019111903502380700_B57","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.bbmt.2013.09.001","article-title":"An intermediate alemtuzumab schedule reduces the incidence of mixed chimerism following reduced-intensity conditioning hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis","volume":"19","author":"Marsh","year":"2013","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/130\/25\/2728\/1404373\/blood788349.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/130\/25\/2728\/1404373\/blood788349.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T03:50:57Z","timestamp":1574135457000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/130\/25\/2728\/36884\/Confirmed-efficacy-of-etoposide-and-dexamethasone"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,21]]},"references-count":57,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2017,12,21]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2017-06-788349","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,21]]}}}